흡수성 안과용 봉합사 시장 : 세계 예측(2026-2032년)

The Absorbable Ophthalmic Sutures Market is projected to grow by USD 2.95 billion at a CAGR of 6.29% by 2032.

Absorbable Ophthalmic Sutures: Executive Overview

Absorbable ophthalmic sutures are sterile, temporary wound-closure materials used in procedures including cataract surgery, corneal repair, glaucoma intervention, and oculoplastic care. Their clinical value is linked to secure tissue approximation while gradually breaking down, potentially reducing the need for suture-removal visits. Selection depends on tissue type, required support duration, handling characteristics, inflammatory response, needle design, and surgeon preference. Demand is shaped by ophthalmic procedure volumes, aging populations, access to surgical care, and standards for sterile medical devices.

Clinical Practice Is Shifting Toward Precision, Convenience, and Biocompatibility

The landscape is moving toward finer sutures, atraumatic needle profiles, predictable absorption, and packaging that supports efficient sterile workflow. Surgeons increasingly balance tensile support with minimal tissue reaction, particularly in delicate corneal and conjunctival applications. Procedure-specific design, consistent handling, and compatibility with microsurgical techniques are becoming more important as ophthalmic care expands across hospitals, ambulatory centers, and specialist clinics. Regulatory scrutiny, traceability, and infection-control requirements also continue to influence product selection and procurement.

Artificial Intelligence Improves Planning, Training, and Quality Oversight

Artificial intelligence is contributing to ophthalmology through image analysis, surgical planning, workflow optimization, and postoperative monitoring. These capabilities can help identify anatomical features, support case selection, and improve documentation, although they do not replace surgeon judgment or validated clinical evidence. For absorbable sutures, AI may assist with procedure analytics, inventory planning, adverse-event signal detection, and assessment of healing patterns in appropriately governed datasets. Adoption depends on data quality, interoperability, cybersecurity, explainability, and compliance with medical-device and patient-privacy requirements.

Regional Insights: Access, Procedure Mix, and Regulation Shape Adoption

North America is characterized by advanced ophthalmic infrastructure, strong ambulatory surgery activity, and detailed procurement and compliance requirements. Europe combines mature specialist services with harmonized yet nationally implemented regulatory and reimbursement frameworks. Asia-Pacific includes highly developed surgical markets alongside rapidly expanding access, creating varied needs for premium microsurgical products and cost-sensitive solutions. Latin America is influenced by unequal access, public-private care differences, and import conditions. The Middle East is supported by specialized hospitals and investment in healthcare capacity, while Africa shows substantial unmet need alongside major variation in surgical availability, training, supply continuity, and sterile-product access.

Group Insights: Trade, Regulation, and Health-System Coordination Matter

ASEAN markets reflect diverse regulatory systems, healthcare resources, and levels of ophthalmic specialization, making distributor capability and registration expertise important. BRICS countries span large and contrasting patient populations, domestic manufacturing capabilities, and public-sector procurement environments. The European Union benefits from coordinated regulatory principles but retains national differences in reimbursement and purchasing. G7 members generally have sophisticated surgical ecosystems, evidence expectations, and quality controls. GCC countries emphasize tertiary-care capacity, specialist recruitment, and centralized or institutional procurement. NATO members represent varied health systems, but many maintain strong requirements for device quality, supply resilience, and clinical governance.

Country Insights Across Major Ophthalmic Care Markets

Australia and Canada combine organized health systems with geographically dispersed care needs. The United States has extensive specialist and ambulatory ophthalmic activity, with strong emphasis on compliance, outcomes, and supply reliability. Brazil and Mexico face pronounced regional differences in access and procurement. China and India combine large clinical ecosystems with diverse public, private, and domestic supply channels. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom have established ophthalmic services, although reimbursement structures, tendering practices, and regulatory implementation differ. Russia's market environment is shaped by healthcare access variation, sourcing considerations, and broader trade constraints. Across these countries, product acceptance depends on clinical familiarity, demonstrated sterility, handling performance, and dependable distribution.

Actions for Leaders: Build Evidence, Resilience, and Procedure-Specific Value

Industry leaders should align suture design with clearly defined ophthalmic procedures and document absorption, tensile behavior, tissue response, sterility, and handling performance through appropriate testing. Build region-specific regulatory and reimbursement plans rather than assuming a uniform pathway. Strengthen supply resilience through qualified sources, robust quality systems, demand monitoring, and contingency inventory for critical components. Support surgeons with practical training, transparent instructions, and evidence-based comparisons. Use digital and AI-enabled tools only where governance, validation, privacy, and human oversight are clear. Partnerships with hospitals, surgical centers, distributors, and professional education networks can improve appropriate adoption without relying solely on price.

Research Methodology: Evidence-Led Assessment of Clinical and Market Conditions

This executive summary uses a structured qualitative assessment of absorbable ophthalmic sutures, considering clinical applications, product characteristics, regulatory expectations, healthcare access, procurement dynamics, technological change, and regional variation. Geographic interpretation incorporates North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, with additional comparison across the specified country and multinational groupings. Conclusions are framed from publicly verifiable categories of evidence such as clinical practice, device regulation, health-system organization, surgical infrastructure, and supply-chain conditions. No market estimates, market sizing, market shares, or forecasts are included.

Conclusion: Competing Through Reliable Clinical Performance and Access

Absorbable ophthalmic sutures occupy a specialized role in microsurgical wound management, where small differences in handling, tissue response, absorption behavior, and sterility can affect clinical confidence. The strongest opportunities for responsible progress lie in procedure-specific innovation, rigorous evidence, resilient distribution, and support for safe use across unequal healthcare settings. Regional and country conditions require tailored regulatory, commercial, and training strategies. Leaders that combine dependable product quality with clinically relevant education and disciplined digital adoption will be better positioned to support ophthalmic care as surgical needs and technologies evolve.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Absorbable Ophthalmic Sutures Market, by Material Type

• 7.1. Introduction
• 7.2. Poliglecaprone
• 7.3. Polyglactin
  • 7.3.1. Ratio 85/15
  • 7.3.2. Ratio 90/10
• 7.4. Polyglycolic Acid

8. Absorbable Ophthalmic Sutures Market, by Suture Type

• 8.1. Introduction
• 8.2. Braided
• 8.3. Monofilament
  • 8.3.1. Dry Extrusion
  • 8.3.2. Melt Extrusion

9. Absorbable Ophthalmic Sutures Market, by Stitch Size

• 9.1. Introduction
• 9.2. 6-0
• 9.3. 7-0
• 9.4. 8-0

10. Absorbable Ophthalmic Sutures Market, by Application

• 10.1. Introduction
• 10.2. Cataract
  • 10.2.1. Extracapsular Cataract Extraction
  • 10.2.2. Phacoemulsification
• 10.3. Corneal
• 10.4. Glaucoma
• 10.5. Pediatric
• 10.6. Retinal

11. Absorbable Ophthalmic Sutures Market, by End User

• 11.1. Introduction
• 11.2. Ambulatory Surgery Centers
• 11.3. Clinics
• 11.4. Hospitals
  • 11.4.1. Private Hospitals
  • 11.4.2. Public Hospitals

12. Absorbable Ophthalmic Sutures Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Absorbable Ophthalmic Sutures Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Absorbable Ophthalmic Sutures Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. 3S Corporation
• 16.2. A. D. Surgical
• 16.3. Adva Medical India Private Limited
• 16.4. Alcon Inc.
• 16.5. Asssut Medical
• 16.6. B. Braun Melsungen AG
• 16.7. Bentley Healthcare Private Limited
• 16.8. Betatech Medical
• 16.9. Bio Sud Medical Systems
• 16.10. Biocomposites
• 16.11. Boston Scientific Corporation
• 16.12. Changzhou Zener Medtec
• 16.13. ConMed Corporation
• 16.14. Cygnet Meditech Private Limited
• 16.15. DemeTECH Corporation
• 16.16. Denmg Healthcare
• 16.17. Ethicon Inc.
• 16.18. FCI Opthalmics
• 16.19. Healthium Medtech Limited
• 16.20. Heska Corporation
• 16.21. HLL Lifecare Limited
• 16.22. Jiangsu Huida Medical Instruments
• 16.23. KATSAN Medical Devices

17. Key Experts